StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / enarabio.com

Enara Bio

Enara Bio (enarabio.com): 1 change recorded in its website history since August 2020. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeIlluminating the immune interface to develop new cancer therapies
    AfterAdvancing cancer immunotherapy by targeting the unconventional

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 12 August 2020

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Illuminating the immune interface to develop new cancer therapies

Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2022 – November 2026 · 10 captures · latest observed messagingUnleashing unconventional antigens for cancer immunotherapy

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 10 captures in this group
    • 1 July 2022 · Advancing cancer immunotherapy by targeting the unconventional archived page
    • 3 February 2023 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 7 July 2023 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 3 January 2024 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 22 January 2025 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 9 July 2025 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 8 January 2026 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 21 April 2026 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 18 May 2026 · Unleashing unconventional antigens for cancer immunotherapy archived page
    • 6 November 2026 · Unleashing unconventional antigens for cancer immunotherapy current websiteHistorical capture not publicly available
  2. August 2020 – August 2021 · 3 capturesIlluminating the immune interface to develop new cancer therapies

    Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by

    This wording observed 3 August 2021.

    archived page
    Inspect 3 captures in this group
    • 12 August 2020 · Illuminating the immune interface to develop new cancer therapies archived page
    • 12 January 2021 · Illuminating the immune interface to develop new cancer therapies archived page
    • 3 August 2021 · Illuminating the immune interface to develop new cancer therapies archived page

Cite this record

StartupHistory, “Enara Bio” company record, https://startuphistory.org/c/enarabio.com

Machine-readable: /c/enarabio.com.json. How changes are found: method.